Taiwan: IP office issues update on unity-of-invention requirement

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Taiwan: IP office issues update on unity-of-invention requirement

According to Article 33 of the Patent Law, invention patent applications should be filed on a case-by-case basis. Where two or more inventions are so linked that they form a single general inventive concept, they may be claimed in a single application. In other words, a single application can cover two or more inventions only when the claimed inventions are in possession of a common feature which is novel or non-obvious over the prior art.

As there are some grey areas in the criteria for determining whether an invention patent application meets the unity-of-invention requirement set out in Article 33 of the Patent Law, recently, Taiwan's IP office, after seeking opinions from practitioners, has introduced amendments to the new criteria implemented from January 1 2019. The following are the main amendments meriting the applicant's attention:

1) An examiner should have completed examination of a set of claims as to novelty and inventive step of the claimed invention when he/she raises the unity-of-invention issue. In other words, it is not permissible for an examiner to issue an official letter/office action merely based on the unity-of-invention issue. In principle, the examiner should choose Claim 1 and its dependent claims as the basis for preliminary examination.

2) If an applicant fails to overcome the lack-of-unity rejection after filing an amendment or argument against an official letter in which the examiner has raised not only the novelty and/or inventive step issue but also the unity-of-invention issue, the examiner may formally reject the application. At that time, it is a must for the applicant who wishes to further prosecute the application to file a request for re-examination.

3) If an examiner has rejected all the claims for being devoid of novelty or inventive step, he/she cannot raise a lack-of-unity rejection afterwards. The underlying rationale is that the applicant should be given full opportunity to file amendments or arguments in an unfavourable situation.

In view of the above amendments, the applicant is advised to: (1) define the most essential feature of an invention in Claim 1 and its dependent claims; (2) file a set of revised claims to meet the examiner's requirement, if acceptable, and to, in turn, obviate the unity-of-invention rejection; and (3) pay special attention to the respective deadlines for filing divisional applications at different stages and file divisional applications at appropriate times.

lin.jpg

Chiu-ling Lin


Saint Island International Patent & Law Offices7th Floor, No. 248, Section 3Nanking East RoadTaipei 105-45, Taiwan, ROCTel: +886 2 2775 1823Fax: +886 2 2731 6377siiplo@mail.saint-island.com.twwww.saint-island.com.tw

more from across site and SHARED ros bottom lb

More from across our site

AG Barr acquires drinks makers Fentimans and Frobishers, in deals worth more than £50m in total
Tarun Khurana at Khurana & Khurana says corporates must take the lead if patent filing activity is to truly translate into innovation
Michael Moore, head of legal at Glean AI, discusses how in-house IP teams can use AI while protecting enforceability
Counsel for SEP owners and implementers are keeping an eye on the case, which could help shape patent enforcement strategy for years to come
Jacob Schroeder explains how he and his team secured victory for Promptu in a long-running patent infringement battle with Comcast
After Matthew McConaughey registered trademarks to protect his voice and likeness against AI use, lawyers at Skadden explore the options available for celebrities keen to protect their image
The Via members, represented by Licks Attorneys, target the Chinese company and three local outfits, adding to Brazil’s emergence as a key SEP litigation venue
The firm, which has revealed profits of £990,837, claims it is the disruptive force in the IP-legal industry
In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date
Arun Hill at Clarivate assesses the Top 100 Global Innovators 2026 list, including why AI has assumed a strategic importance for innovation
Gift this article